期刊文献+

突变型干扰素-τ的表达、纯化及其抗乙型肝炎病毒作用

Expression,Purification and Anti-HBV Effect of Mutant Interferon-τ
下载PDF
导出
摘要 目的在毕赤酵母中表达突变型干扰素-τ(IFN-τ),并检测其生物学活性及抗乙型肝炎病毒作用。方法将绵羊IFN-τ序列中6个氨基酸突变为人IFN-α相应的氨基酸,将合成的基因克隆至pPICZα质粒,构建突变型IFN-τ表达质粒pPICZα-IFN-τ,转化巴斯德毕赤酵母中进行高密度发酵。发酵上清液经超滤浓缩、离子交换层析和分子筛层析纯化后,检测其生物学活性及抗乙型肝炎病毒作用,并与市售IFN-α2a进行比较。结果发酵上清液中突变型IFN-τ的表达量为400~500mg/L,占上清总蛋白的40%以上;纯化收率达31.4%,纯度约为95%;比活为2.1×107IU/mg;对乙型肝炎病毒的抑制作用与IFN-α2a相当,但细胞毒性显著低于后者。结论已在毕赤酵母中高效表达了突变型IFN-τ,表达的蛋白具有较高的生物学活性,对乙型肝炎病毒有良好的抑制作用,且细胞毒性较低。 Objective To express mutant interferon-τ (IFN-τ) in Pichia pastoris, purify the expressed product and study its anti-HBV effect. Methods Substitute the 6 amino acids in sheep IFN-τ sequence to the responding amino acids in human IFN-α, and clone the synthetic gene to plasmid pPICZα. Transform the constructed recombinant plasmid pPICZα-IFN-τ for expression of mutant IFN-τ to Piehia pastoris, for high density fermentation. The fermentation supernatant was concentrated by ultrafiltration, purified by ion exchange and molecular chromatography and determined for biological activity, Evaluate the anti-HBV effect of expressed protein and compare with that of commercial IFN-α2a. Results The expression level of IFN-τ in fermentation supernatant was 400 - 500 mg/ L. The expressed product contained more than 40% of total protein in supernatant and reached a recovery rate of 31.4%, a purity of about 95% and a specific activity of 2.1×10^7IU/mg. The anti-HBV effect of the expressed IFN-τ was equal to, while the cytotoxicity was lower than that of commercial IFN-α2a. Conclusion Mutant IFN-τ with high biological activity was successfully expressed in Pichia pastoris,, which showed significantly inhibitory effect on HBV and low cytotoxicity.
出处 《中国生物制品学杂志》 CAS CSCD 2008年第11期988-991,共4页 Chinese Journal of Biologicals
基金 浦东新区科技专项基金项目(PKJ2004-76)
关键词 干扰素-τ 突变型 毕赤酵母 抗病毒作用 乙型肝炎病毒 Interferon-τ Mutant Pichia pastoris, Antiviral effect Hepatitis B virus
  • 相关文献

参考文献13

  • 1I Martal JL, Chine NM, Huynh LP, et al. IFN-tau: a novel subtype Ⅰ IFN1. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities. Biochimie,1998, 80(8- 9): 755-777.
  • 2Roberts RM. Interferon-tau, a type 1 interferon involved in maternal recognition of pregnancy. Cytokine Growth Factor Rev, 2007, 18 (5-6): 403-408.
  • 3Radhakrishnan R, Walter LJ, Subramaniam PS, et ah Crystal structure of ovine interferon-tau at 2.1 A resolution. J Mol Biol, 1999, 286 (1): 151-162.
  • 4Shorts LH, Dancz CE, Shupp JW, et al. Characterization of N-terminal interferon tau mutants: P26L affords enhanced activity and lack of toxicity. Exp Biol Med (Maywood), 2004, 229 (2): 194-202.
  • 5Subramaniam PS, Khan SA, Pontzer CH, et al. Differential recognition of the type Ⅰ interferon receptor by interferon stau and alpha is responsible for their disparate cytotoxicities. Proc Natl Acad Sci USA, 1995, 92 (26): 12270-12274.
  • 6Pontzer CH, Yamamoto JK, Bazer FW, et al. Potent anti-feline immunodeficiency virus and anti-human immunodeficiency vitals effect of IFN-tau. J Immunol, 1997 , 158 (9): 4351-4357.
  • 7Soos JM, Subramaniam PS, Hobeika AC, et al. The IFN pregnancy recognition hormone IFN-tau blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity. J Immunol, 1995, 155(5): 2747-2753.
  • 8Katayama DS, Nayar R, Chou DK, et al. Solution behavior of a novel type 1 interferon, interferon-tau. J Pharm Sci, 2005, 94 (12): 2703-2715.
  • 9Loftis JM, Hauser P. The phenomenology and treatment of interferon-induced depression. J Affect Disord, 2004, 82 (2): 175-190.
  • 10Hauschild A, Gogas H, Tarhini A, et al. Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion. Cancer, 2008, 112(5): 982-994.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部